Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T

Clinical trial NCT00209833 · UNKNOWN

Trial details

NCT number: NCT00209833
Sponsor: Hannover Medical School
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

De Novo Akute Myeloid Leukemia (AML)Secondary Acute Myeloid Leukemia (AML)Refractory Anemia With Excess of Blasts in Transformation

Start date: 1999-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.